Thomas Klein
Family Medicine · Wichita, KSNPI 1528020195
Payments from drug & device makers
Across 571 payments — averaging $5900.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1.3M
- Astrazeneca UK Limited$791K
- Pfizer$339K
- Eisai Inc.$273K
- Ironwood Pharmaceuticals, Inc$180K
- Eli Lilly$127K
- plus $381K from 30 others
Across 3 payments — averaging $428.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1K
What the payments were for
- Travel & lodging$48713%
- Food & beverage$3,18087%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $1,277,761 |
| Astrazeneca UK Limited | 9 | $790,578 |
| Pfizer | 46 | $339,135 |
| Eisai Inc. | 154 | $272,992 |
| Ironwood Pharmaceuticals, Inc | 26 | $179,728 |
| Eli Lilly | 10 | $127,491 |
| GSK | 58 | $113,901 |
| Currax Pharmaceuticals LLC | 15 | $111,224 |
| Organon | 22 | $75,564 |
| Modernatx, Inc. | 15 | $34,893 |
| AMAG Pharmaceuticals, Inc. | 9 | $32,723 |
| Myovant Sciences GmbH | 2 | $10,600 |
| Amgen | 43 | $581 |
| AbbVie(2 entities) | 45 | $510 |
| Novo Nordisk | 43 | $458 |
| Lilly USA, LLC | 15 | $176 |
| Sanofi-aventis U.S. LLC | 10 | $136 |
| Amarin Pharma, Inc. | 7 | $96 |
| Teva Pharmaceuticals USA, Inc. | 6 | $70 |
| Abbott | 4 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $48 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $44 |
| Nestle Healthcare Nutrition Inc. | 2 | $41 |
| Bayer | 2 | $39 |
| Esperion Therapeutics, Inc. | 3 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $24 |
| Glaukos Corporation | 1 | $19 |
| Novartis | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Apria Healthcare LLC | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Medtronic | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
| Johnson & Johnson | 1 | $11 |
| Neos Therapeutics, LP | 1 | $11 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COLOGUARD$107
How this compares
$3,369,048 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Wichita
- Terry PolingWichita$24.2M
- Terry KleinWichita$5.9M
- Richard EgelhofWichita$4.1M
- Brandon AllemanWichita$3M
- Tracy KleinWichita$2.7M
- William SimonWichita$1.1M
- Tana GoeringWichita$1.1M
- Gregory LakinWichita$897K
- Timothy KoehlerWichita$675K
- Neal SecristWichita$539K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.